Becton, Dickinson & Stock News

FRANKLIN LAKES, N.J. , Oct. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States.

Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.

For my followup on medtech stock Becton, Dickinson and Company, I'm reaffirming my prior buy rating, agreeing with the Wall St consensus today. Becton, Dickinson's growing and globally diverse portfolio should continue to address the macro clinical demand in several areas. Despite unsteady cashflow growth trends, BDX continued to grow dividends steadily while also making major capital investments.

FRANKLIN LAKES, N.J. , Oct. 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care Platform, a new scalable, AI-enabled, cloud-based platform that unifies BD device data into one intelligent ecosystem for the first time.

OneMain is a scale leader in nonprime personal lending. The macro backdrop has given us the opportunity to own OneMain at an attractive valuation. Becton, Dickinson's valuation is attractive given the company's defensive attributes and growth potential. Greggs' strong brand and differentiated business model have created loyal customers and long-term market share gains.

Chevron, Sherwin-Williams, and Becton, Dickinson and Company sport a market-doubling 2.5% dividend yield and trade at 6% to 21% discounts to our fair value estimates. CVX's combination of production growth and continued execution on cost efficiencies should drive growth for the foreseeable future. SHW is expected to return to healthy growth, with lower interest rates and well-known brands being...

BROKEN BOW, Neb. , Oct. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of manufacturing excellence at its Broken Bow, Nebraska facility—a cornerstone of BD's extensive U.S. manufacturing network.

Becton Dickinson said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, to pursue a new professional opportunity.